URL has been copied successfully!
U.S. stock futures were higher this morning, with the Dow futures gaining around 1,000 points on Monday.
Shares of Valneva SE (NASDAQ:VALN) fell sharply in pre-market trading.
Pfizer (NYSE:PFE) and Valneva disclosed topline results from Phase 3 VALOR clinical trial of investigational 6-Valent OspA-based Lyme disease vaccine candidate PF-0730740.
Valneva shares dipped 14% to $8.88 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- LiveWire Group Inc (NASDAQ:LVWR) shares dipped 14.6% to $1.04 in pre-market trading after dipping 10% on Friday.
- Anghami …
This post was originally published here


